InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,314.96
(
-2.42%
)
US TECH 100
17,852.00
(
-2.91%
)
Dow Jones
39,460.77
(
-2.20%
)
Brent Oil
77.20
(
-3.47%
)
Bitcoin
62,719.68
(
-4.04%
)
Post# of 252775
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 834
Posts 120193
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 164584

Thursday, 11/14/2013 1:35:19 PM

Thursday, November 14, 2013 1:35:19 PM

Post# of 252775
US third-party payers will strongly embrace generic Copaxone (according to Craig Wheeler on MNTA’s webcast today) because there are currently no US generic drugs for multiple sclerosis.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up